Fusion Antibodies plc (LON:FAB – Get Free Report) dropped 1.2% during trading on Wednesday . The company traded as low as GBX 10.60 and last traded at GBX 10.62. 107,224 shares were traded during mid-day trading, a decline of 75% from the average daily volume of 431,250 shares. The stock had previously closed at GBX 10.75.
Fusion Antibodies Stock Down 1.2%
The company has a debt-to-equity ratio of 92.42, a current ratio of 1.80 and a quick ratio of 2.36. The firm’s 50 day moving average price is GBX 12.38 and its two-hundred day moving average price is GBX 13.23. The firm has a market cap of £13.29 million, a price-to-earnings ratio of -7.08 and a beta of 1.22.
About Fusion Antibodies
The Company’s ordinary shares were admitted to trading on AIM on 18 December 2017. Fusion provides a broad range of services in antibody generation, development, production, characterisation and optimisation. These services include antigen expression, antibody production, purification and sequencing, antibody humanisation using Fusion’s proprietary CDRx TM platform and the production of antibody generating stable cell lines to provide material for use in clinical trials.
Featured Stories
- Five stocks we like better than Fusion Antibodies
- Why Johnson & Johnson’s Earnings Dip Looks Like a Buying Opportunity
- CPI Comes In Cool: Why It Could Revive These 3 Rate-Sensitive Stocks
- Why ASML’s AI Monopoly Is Still Getting Stronger
- Apple’s AI Toll Booth Thesis Faces Its Biggest Test Yet Before Earnings
Receive News & Ratings for Fusion Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fusion Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
